Literature DB >> 28331655

A Rare Breast Tumor Confused with Ductal Carcinoma in Situ, Primary Solid Neuroendocrine Carcinoma.

Ömer Alıcı1, Serap Korkmaz Aydoğdu2.   

Abstract

The concept of pure neuroendocrine breast tumors was initially defined by Sapino et al. There are three sub-types of these tumors: solid, small cell/oat cell, and large cell neuroendocrine carcinomas. To diagnose neuroendocrine tumors, more than half of the tumor cells must have neuroendocrine differentiation. The possibility of metastatic neuroendocrine carcinoma must always be excluded in the differential diagnosis. In addition, it should be considered that solid neuroendocrine (NE) carcinomas can be confused with ductal carcinoma in situ due to their similar morphologic appearance. In this article, a patient with primary solid neuroendocrine breast cancer who had been diagnosed with ductal carcinoma in situ at another center was presented along with morphological and immunohistochemical features.

Entities:  

Keywords:  Neuroendocrine carcinoma; breast; solid

Year:  2014        PMID: 28331655      PMCID: PMC5351469          DOI: 10.5152/tjbh.2014.1725

Source DB:  PubMed          Journal:  J Breast Health        ISSN: 1306-0945


  8 in total

Review 1.  Expression of the neuroendocrine phenotype in carcinomas of the breast.

Authors:  A Sapino; L Righi; P Cassoni; M Papotti; F Pietribiasi; G Bussolati
Journal:  Semin Diagn Pathol       Date:  2000-05       Impact factor: 3.464

Review 2.  Small cell neuroendocrine carcinoma of the breast: a report of three cases and review of the literature.

Authors:  T Adegbola; C E Connolly; G Mortimer
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

3.  Primary solid neuroendocrine carcinoma of the breast.

Authors:  Wided Stita; Amel Trabelsi; Olfa Gharbi; Moncef Mokni; Sadok Korbi
Journal:  Can J Surg       Date:  2009-12       Impact factor: 2.089

4.  Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.

Authors:  W Y Tsang; J K Chan
Journal:  Am J Surg Pathol       Date:  1996-08       Impact factor: 6.394

5.  Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases.

Authors:  M Papotti; L Macrì; G Finzi; C Capella; V Eusebi; G Bussolati
Journal:  Semin Diagn Pathol       Date:  1989-05       Impact factor: 3.464

6.  Primary small cell carcinoma of the breast with TTF-1 and neuroendocrine marker expressing carcinoma in situ.

Authors:  Michael Christie; Laura Chin-Lenn; Monique M Watts; Alpha E Tsui; Malcolm R Buchanan
Journal:  Int J Clin Exp Pathol       Date:  2010-06-30

7.  Synchronous metastases to the liver and pancreas from a primary neuroendocrine carcinoma of the breast diagnosed by fine-needle aspiration.

Authors:  Maria McIntire; Kalliopi Siziopikou; Jyothi Patil; Paolo Gattuso
Journal:  Diagn Cytopathol       Date:  2008-01       Impact factor: 1.582

8.  Management of neuroendocrine carcinomas of the breast: A rare entity.

Authors:  Yesim Yildirim; Sahende Elagoz; Ayhan Koyuncu; Cengiz Aydin; Kursat Karadayi
Journal:  Oncol Lett       Date:  2011-05-23       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.